PUBLISHER: IMARC | PRODUCT CODE: 2032471
PUBLISHER: IMARC | PRODUCT CODE: 2032471
The global pressure infusion bags market size reached USD 369.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 581.7 Million by 2034, exhibiting a growth rate (CAGR) of 5.02% during 2026-2034. The rising prevalence of chronic diseases, extensive research and development (R&D) activities, and the increasing geriatric population represent some of the key factors driving the market.
A pressure infusion bag is a special medical delivery device used to pressurize sterile parenteral fluids into patients. It is manufactured using nylon, later, and polyurethane materials that provide excellent visibility of the fluid bag levels. It is widely used for fast intravenous (IV) infusion, autotransfusion, invasive pressure monitoring, and fluid delivery during minimally invasive surgery. A pressure infusion bag is a safe, high-quality, reliable, and effective device for intravenous and intra-arterial infusion treatment. It is commonly used for patients suffering from trauma-induced and postpartum haemorrhage and cardiac surgery. It also helps to minimize the chances of cross-contamination during the fluid infusion process, thus making them an effective tool to ensure patient safety.
The rising prevalence of chronic diseases and the surge in emergency transfusion cases across the globe is one of the key factors driving the market growth. Pressure infusion bags are widely used in clinical emergencies, intensive care units (ICUs), anesthesia departments, and other clinical settings. In line with this, the widespread product adoption due to the growing importance of invasive pressure monitoring and assessment of wounds in arterial conditions is favoring the market growth. Additionally, the increasing product utilization within perioperative settings by anesthesiologists to control flow rates and enhance patient safety is acting as another growth-inducing factor. Apart from this, key players are focusing on the development of automated pressure infuser bags that assist in reducing manual infections and the possibility of accidental air embolism, which, in turn, is providing an impetus to the market growth. Moreover, the increasing demand for disposable pressure infuser bags prevents cross-contamination and eliminates costly cleaning and repairs of reusable bags is propelling the market growth. Besides this, the rising focus of manufacturers toward the upsurge in the demand for cost-effective and reliable products is positively influencing the market growth. Furthermore, the widespread product adoption in intra-arterial pressure monitoring and Swan-Ganz catheterization monitoring to slow the retrograde flow of blood and keep the indwelling catheter patent is providing a considerable boost to the market growth. Other factors, including extensive research and development (R&D) activities, significant expansion in the healthcare industry, the introduction of oval pressure infusion bags, increasing adoption of state-of-the-art medical facilities, and the rising geriatric population, are anticipated to drive the market further toward growth.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for pressure infusion bags. Some of the factors driving the North America pressure infusion bags market included the rising geriatric population, the widespread utilization of disposable pressure infusion bags, and various product innovations.
The report has also provided a comprehensive analysis of the competitive landscape in the global pressure infusion bags market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ASP Global LLC, Biegler GmbH, Eakin Healthcare Group Ltd, Friedrich Bosch GmbH & Co. KG, ICU Medical Inc.Merit Medical Systems Inc., Rudolf Riester GmbH (Halma plc), Sarstedt AG & Co. KG, SunMed LLC, Tapmedic LLC, VBM Medizintechnik GmbH, Vyaire Medical Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.